| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.948 | 13.865 | 23.677 | 24.049 | 23.469 | 34.010 | 24.516 | 31.807 | 134.416 |
| Total Income - EUR | - | 1.948 | 13.865 | 23.678 | 24.049 | 23.470 | 34.011 | 26.480 | 31.809 | 134.622 |
| Total Expenses - EUR | - | 1.303 | 7.119 | 7.641 | 9.870 | 4.571 | 3.578 | 4.550 | 10.947 | 51.695 |
| Gross Profit/Loss - EUR | - | 645 | 6.746 | 16.037 | 14.179 | 18.899 | 30.433 | 21.930 | 20.862 | 82.927 |
| Net Profit/Loss - EUR | - | 587 | 6.330 | 15.327 | 13.458 | 18.243 | 29.595 | 21.304 | 17.294 | 78.894 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Bumbaru Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 1.042 | 1.276 | 987 | 1.305 | 736 | 2.307 | 48.394 | 45.865 |
| Current Assets | - | 664 | 6.031 | 21.103 | 34.429 | 19.698 | 42.293 | 41.382 | 12.504 | 73.975 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.035 | 1.496 | 1.467 | 1.439 | 3.059 | 1.413 | 8.205 | 33.726 |
| Cash | - | 664 | 4.996 | 19.607 | 32.963 | 18.259 | 39.234 | 39.970 | 4.298 | 40.249 |
| Shareholders Funds | - | 631 | 6.950 | 22.149 | 35.178 | 18.293 | 42.429 | 42.520 | 59.685 | 78.956 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 33 | 122 | 229 | 239 | 2.985 | 600 | 1.169 | 1.212 | 40.884 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bumbaru Med Srl